Results 71 to 80 of about 8,379,610 (258)
ABSTRACT Sub‐Saharan Africa (SSA) continues to experience a high and uneven disease burden, mainly from HIV/AIDS, tuberculosis, and malaria. As external funding declines, the strategic allocation of domestic public health spending (DPHS) becomes crucial.
Wa Ntita Serge Kabongo, Josue Mbonigaba
wiley +1 more source
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection [PDF]
Although the pathogenesis of human immunodeficiency virus (HIV) infection and the general virologic and immunologic principles underlying the use of antiretroviral therapy are similar for all HIV-infected persons, there are unique considerations needed ...
Health Resources and Services Administration, HRSA +3 more
core
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection [PDF]
Although antiviral agents which block human immunodeficiency virus (HIV) replication can result in long-term suppression of viral loads to undetectable levels in plasma, long-term therapy fails to eradicate virus, which generally rebounds after a single ...
Ruiz, L +9 more
core +1 more source
Girma Ashenafi,1 Melatwork Tibebu,2 Dagnamyelew Tilahun,1 Aster Tsegaye2 1Department of Medical Laboratory Sciences, Bule Hora University, Bule Hora, Oromia, Ethiopia; 2Department of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa ...
Ashenafi G +3 more
doaj
Abstract Background Prior cesarean delivery (CD) is a leading indication for repeat CD and a key driver of rising cesarean rates in Sub‐Saharan Africa. Evidence on associations between prior CD and adverse outcomes in low‐resource settings remains limited.
Leevan Tibaijuka +9 more
wiley +1 more source
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration [PDF]
Background The genetic differences among HIV-1 subtypes may be critical to clinical management and drug resistance surveillance as antiretroviral treatment is expanded to regions of the world where diverse non-subtype-B viruses predominate.Methods and ...
Wynhoven, B +61 more
core +2 more sources
Verification study enabled the detection of HIV false reactivity ranging from 0‐4% across rapid diagnostic tests. A reliable three‐tests algorithm ranked First Response HIV 1‐2‐0 Card, First Response HIV1+2/Syphilis Combo or STANDARD Q as suitable test 1 to mitigate false positive events. As countries move toward HIV elimination, implementing the three‐
Rogers Ajeh Awoh +34 more
wiley +1 more source
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients
Darunavir (DRV) is an HIV-1 protease inhibitor that is used together with a low boosting dose of ritonavir as part of an antiretroviral therapy (ART) regimen in treatment-experienced and naïve HIVpositive patients.
Massimiliano Lanzafame +4 more
doaj +1 more source
Maintaining infants and children on highly active antiretroviral therapy
No abstract available.
Helena Rabie +2 more
doaj +1 more source
Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati
Purpose: Human immunodeficiency virus-infected patients do not adhere to their antiretroviral therapy (ART) due to adverse effects of drugs. The continuous monitoring of adverse drug reactions (ADRs) may ensure the safe use of drugs in patients. Hence, a
Rajalakshmi Rukmangathen +5 more
doaj +1 more source

